Thirteen-week dose-intensifying simultaneous combination chemotherapy protocol for malignant lymphoma in dogs

Zenker, I.; Meichner, K.; Steinle, K.; Kessler, M.; Hirschberger, J.
November 2010
Veterinary Record: Journal of the British Veterinary Association;Nov2010, Vol. 167 Issue 19, p744
Academic Journal
This prospective study aimed to record the toxicity profile of a dose-intensifying simultaneous chemotherapy (DISC) protocol for lymphoma in dogs. Remission rates and the duration of the protocol were also evaluated. Twenty-one dogs were studied. Diagnosis was based on cytological or histological assessments. The DISC protocol is a 13-week maintenance-free protocol. L-Asparaginase (400 iu/kg) was administered subcutaneously on day 1, followed by weekly simultaneous intravenous administration of vincristine (0.7 mg/m = 100 per cent), cyclophosphamide (200 mg/m = 100 per cent) and doxorubicin (30 mg/m = 100 per cent) at a starting dose level of 33 per cent. Dose levels were given twice and then increased by 5 to 7 per cent if grade 0 or I toxicities were seen, to a maximum dose level of 60 per cent. Two dogs experienced a grade IV toxicity (asymptomatic neutropenia in one dog and sepsis in the other). Two episodes of asymptomatic grade III thrombocytopenia and one episode of neutropenia were recorded. Other toxic events were infrequent and mild. Only one dog required hospitalisation for less than 72 hours. Seventeen dogs (80.9 per cent) achieved complete remission, one (4.8 per cent) achieved partial remission, two (9.5 per cent) had stable disease and in one (4.8 per cent) disease progressed.


Related Articles

  • Value of palliative chemotherapy for dogs with lymphoma.  // Veterinary Record: Journal of the British Veterinary Association;3/29/2003, Vol. 152 Issue 13, p404 

    Presents a study about the value of palliative chemotherapy for dogs affected with lymphoma.

  • Lymphoma in 3 related Rottweilers from a single household. Lobetti, R. G. // Journal of the South African Veterinary Association;Jun2009, Vol. 80 Issue 2, p103 

    The article presents a research on the lymphoma in two Rottweiler siblings and their dam which lives in the same household. Lymphoma arises from malignant clonal expansion of lympho-reticular and over a period of almost one year, the dogs in the same household developed stage IV and III...

  • Linfoma canino: clínica, hematologia e tratamento com o protocolo de Madison-Wisconsin. de Cápua, Maria Luisa Buffo; Dela Coleta, Flávia Eiras; Canesin, Ana Paula Massae Nakage; Godoy, Aline Vieira; Calazans, Sabryna Gouveia; Miotto, Mariana Rodrigues; Daleck, Carlos Roberto; Santana, Aureo Evangelista // Ciência Rural;jul2011, Vol. 41 Issue 7, p1245 

    Lymphoma is a neoplasm of high incidence in dogs, and has several clinical signs, depending on the tumor anatomical area and the extent of the disease. This study aimed to evaluate the clinical and hematological findings in dogs with lymphoma at diagnosis, and the clinical evolution during...

  • Treating lymphoma in dogs and cats. Fan, Timothy M.; De Lorimier, Louis-Philippe // Veterinary Medicine;Apr2005, Vol. 100 Issue 4, p285 

    Explores the treatment options for lymphoma in dogs and cats. Hypothesized causes of canine lymphoma; Phases of systemic chemotherapy; Function of corticosteroids.

  • Managing malignant disease in dogs. Polton, Gerry // Veterinary Record: Journal of the British Veterinary Association;11/7/2009, Vol. 165 Issue 19, p576 

    The article reports on clinical trial options for managing malignant disease in dogs. The said trials are intended for dogs with splenic haemangiosarcoma and T cell lymphoma. Study shows that tyrosine kinase inhibitor treatment enhances the sensitivity to chemotherapy in splenic haemangiosarcoma...

  • Carmustine, Vincristine, and Prednisone in the Treatment of Canine Lymphosarcoma. Lucas, Sílvia Regina Ricci; Coelho, Bruna Maria Pereira; Marquezi, Maurício Luis; Franchini, Maria Luisa; Miyashiro, Samantha Ive; Pozzi, Diana Helena de Benedetto // Journal of the American Animal Hospital Association;May2004, Vol. 40 Issue 3, pN.PAG 

    A chemotherapeutic protocol using carmustine in combination with vincristine and prednisone was tested in dogs with multicentric malignant lymphosarcoma. Of seven dogs treated, six (85.7%) achieved complete remission. A partial response occurred in one dog. Median survival time was 224 days...

  • MEDICAL ONCOLOGY PERSPECTIVE. Allstadt, Sara D. // Veterinary Medicine;Oct2014, Vol. 109 Issue 10, p332 

    The article focuses on chemotherapy to treat dogs with transitional cell carcinoma (TCC). It states treatment with NSAIDs is the standard approach for treating TCC. NSAIDs alone or in combination with systemic chemotherapy agents can be used for the treating TCC. It states the combination of...

  • Primary rectal lymphoma: an unusual treatment for a rare case. UnaI, B.; Karabeyoglu, M.; EreI, S.; Bozkurt, B.; Kocer, B,; Cengiz, O. // Postgraduate Medical Journal;Jun2008, Vol. 84 Issue 992, p333 

    Lymphomas may be ocalised throughout the whole gastrointestinal tract, from oral cavity to rectum. The rectum is a fairly uncommon site for lymphoma compared to other gastrointestinal sites. Primary rectal lymphoma is the rarest disorder accounting for 0.1-0.6% of all colonic malignancies, and...

  • Combination Chemotherapy of Advanced Diffuse Histiocytic Lymphoma with the Six-Drug CO-BLAM Regimen. Laurence, Jeffrey; Coleman, Morton; Allen, Steven L.; Silver, Richard T.; Pasmantier, Mark // Annals of Internal Medicine;Aug82, Vol. 97 Issue 2, p190 

    Presents a study that examined the effectiveness of a multiple drug regimen for the treatment of diffuse histiocytic lymphoma. Comparison of combination chemotherapy protocols in previously untreated patients with advanced diffuse histiocytic lymphoma; Analysis of the response of patients to...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics